1 - 25 of
105
results
for author:"Easton D.F."
in Literature Citations
| The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Consortium of Investigators of Modifiers of BRCA1/2 Br. J. Cancer 101:1456-1460(2009) · Mapped (100) |
| Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Collin S.M., Metcalfe C., Zuccolo L., Lewis S.J., Chen L., Cox A., Davis M., Lane J.A., Donovan J., Smith G.D. et al. Cancer Epidemiol. Biomarkers Prev. 18:2528-2539(2009) · Mapped (44) |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Hum. Mol. Genet. 18:4442-4456(2009) · Mapped (65) |
| A genome-wide association study of testicular germ cell tumor. Rapley E.A., Turnbull C., Al Olama A.A., Dermitzakis E.T., Linger R., Huddart R.A., Renwick A., Hughes D., Hines S., Seal S. et al. Nat. Genet. 41:807-810(2009) · Mapped (1) |
| Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Breast Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 18:1610-1616(2009) · Mapped (30) |
| Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. GENICA Consortium Nat. Genet. 41:585-590(2009) · Mapped (14) |
| Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Ovarian Cancer Association Consortium (OCAC) Hum. Mol. Genet. 18:2297-2304(2009) · Mapped (5) |
| Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Schildkraut J.M., Goode E.L., Clyde M.A., Iversen E.S., Moorman P.G., Berchuck A., Marks J.R., Lissowska J., Brinton L., Peplonska B. et al. Cancer Res. 69:2349-2357(2009) · Mapped (31) |
| Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival. Abraham J.E., Harrington P., Driver K.E., Tyrer J., Easton D.F., Dunning A.M., Pharoah P.D. Clin. Cancer Res. 15:2181-2191(2009) · Mapped (35) |
| Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Quaye L., Dafou D., Ramus S.J., Song H., Gentry-Maharaj A., Maharaj A.G., Notaridou M., Hogdall E., Kjaer S.K., Christensen L. et al. Hum. Mol. Genet. 18:1869-1878(2009) · Mapped (31) |
| Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Ovarian Cancer Association Consortium Br. J. Cancer 100:993-1001(2009) · Mapped (31) |
| FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Udler M.S., Meyer K.B., Pooley K.A., Karlins E., Struewing J.P., Zhang J., Doody D.R., MacArthur S., Tyrer J., Pharoah P.D. et al. Hum. Mol. Genet. 18:1692-1703(2009) · Mapped (12) |
| Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Antoniou A.C., Rookus M., Andrieu N., Brohet R., Chang-Claude J., Peock S., Cook M., Evans D.G., Eeles R., Nogues C. et al. Cancer Epidemiol. Biomarkers Prev. 18:601-610(2009) · Mapped (43) |
| A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer. Kote-Jarai Z., Jugurnauth S., Mulholland S., Leongamornlert D.A., Guy M., Edwards S., Tymrakiewitcz M., O'Brien L., Hall A., Wilkinson R. et al. Br. J. Cancer 100:426-430(2009) · Mapped (1) |
| Association of ESR1 gene tagging SNPs with breast cancer risk. Dunning A.M., Healey C.S., Baynes C., Maia A.T., Scollen S., Vega A., Rodriguez R., Barbosa-Morais N.L., Ponder B.A., Low Y.L. et al. Hum. Mol. Genet. 18:1131-1139(2009) · Mapped (53) |
| Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Mavaddat N., Dunning A.M., Ponder B.A., Easton D.F., Pharoah P.D. Cancer Epidemiol. Biomarkers Prev. 18:255-259(2009) · Mapped (689) |
| Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer. Koessler T., Azzato E.M., Perkins B., Macinnis R.J., Greenberg D., Easton D.F., Pharoah P.D. Int. J. Cancer 124:1887-1891(2009) · Mapped (82) |
| No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Association Consortium and Consortium of Investigators of Modifiers of BRCA1/2 Breast Cancer Res. Treat. 117:371-379(2009) · Mapped (45) |
| Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer. Kalmyrzaev B., Pharoah P.D., Easton D.F., Ponder B.A., Dunning A.M. Cancer Epidemiol. Biomarkers Prev. 17:3618-3620(2008) · Mapped (8) |
| Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Ovarian Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 17:3567-3572(2008) · Mapped (1,109) |
| Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Thompson D.J., Healey C.S., Baynes C., Kalmyrzaev B., Ahmed S., Dowsett M., Folkerd E., Luben R.N., Cox D., Ballinger D. et al. Cancer Epidemiol. Biomarkers Prev. 17:3490-3498(2008) · Mapped (8) |
| Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Pooley K.A., Baynes C., Driver K.E., Tyrer J., Azzato E.M., Pharoah P.D., Easton D.F., Ponder B.A., Dunning A.M. Cancer Epidemiol. Biomarkers Prev. 17:3482-3489(2008) · Mapped (61) |
| Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies. Kelemen L.E., Couch F.J., Ahmed S., Dunning A.M., Pharoah P.D., Easton D.F., Fredericksen Z.S., Vierkant R.A., Pankratz V.S., Goode E.L. et al. Breast Cancer Res. 10:R98-R98(2008) · Mapped (4) |
| The effects of common genetic variants in oncogenes on ovarian cancer survival. Quaye L., Gayther S.A., Ramus S.J., Di Cioccio R.A., McGuire V., Hogdall E., Hogdall C., Blaakr J., Easton D.F., Ponder B.A. et al. Clin. Cancer Res. 14:5833-5839(2008) · Mapped (31) |
| Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Mann A., Hogdall E., Ramus S.J., DiCioccio R.A., Hogdall C., Quaye L., McGuire V., Whittemore A.S., Shah M., Greenberg D. et al. Eur. J. Cancer 44:2259-2265(2008) · Mapped (82) |
